TG Therapeutics, Inc.TGTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+74.3%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
+74.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025194.13%
2024103.21%
2023109.45%
202236.68%
2021-26.02%
2020-61.84%
20193.06%
2018-46.91%
2017-50.33%
2016-24.99%